Advertisement
Advertisement

ALMS

ALMS logo

Alumis Inc. Common Stock

24.50
USD
Sponsored
-2.34
-8.70%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

24.63

+0.12
+0.49%

ALMS Earnings Reports

Positive Surprise Ratio

ALMS beat 1 of 6 last estimates.

17%

Next Report

Date of Next Report
Mar 17, 2026
Estimate for Q4 25 (Revenue/ EPS)
$2.89M
/
-$0.96
Implied change from Q3 25 (Revenue/ EPS)
+39.88%
/
-9.43%
Implied change from Q4 24 (Revenue/ EPS)
--
/
+317.39%

Alumis Inc. Common Stock earnings per share and revenue

On Nov 13, 2025, ALMS reported earnings of -1.06 USD per share (EPS) for Q3 25, missing the estimate of -0.93 USD, resulting in a -13.42% surprise. Revenue reached 2.07 million, compared to an expected 2.89 million, with a -28.51% difference. The market reacted with a +4.55% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analysts forecast an EPS of -0.96 USD, with revenue projected to reach 2.89 million USD, implying an decrease of -9.43% EPS, and increase of 39.88% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
For Q3 2025, Alumis Inc. Common Stock reported EPS of -$1.06, missing estimates by -13.42%, and revenue of $2.07M, -28.51% below expectations.
The stock price moved up 4.55%, changed from $5.28 before the earnings release to $5.52 the day after.
The next earning report is scheduled for Mar 17, 2026.
Based on 10 analysts, Alumis Inc. Common Stock is expected to report EPS of -$0.96 and revenue of $2.89M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement